Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348335 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Topical Cyclosporin for Ocular Rosacea
A Phase 4 study, sponsored by Ophthalmic Consultants of Long Island.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT00348335: Completed Phase 4 study, sponsored by Ophthalmic Consultants of Long Island.
NCT00348335 is a Phase 4 study that has completed, run by Ophthalmic Consultants of Long Island. The registered enrollment target is 35 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348335, a Phase 4 study, has completed, sponsored by Ophthalmic Consultants of Long Island.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
Interventions
- DRUG Cyclosporine 0.05%
- DRUG Ocular lubricant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
What the finished NCT00348335 record still lists
NCT00348335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Cyclosporine 0.05% is the first listed.
NCT00348335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00348335 about?
NCT00348335 is a clinical study titled "Efficacy of Topical Cyclosporin for Ocular Rosacea". The purpose of this study is to determine whether Restasis (topical cyclosporin) is effective in the treatment of ocular rosacea
What is the current status of trial NCT00348335?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2006-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00348335?
The interventions under investigation include: Cyclosporine 0.05% (DRUG), Ocular lubricant (DRUG).
Who is sponsoring clinical trial NCT00348335?
This trial is sponsored by Ophthalmic Consultants of Long Island, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00348335's enrollment target sits among peer trials
35 1506th of 2000 higher than 481 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia